Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 2,689-2,700 of 6,115
Drug study icon
CompletedEUCTR 2010-023531-42

The role of vitamin D supplementation on symptoms in patients treated for depression. A double-blind randomized trial.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
Denmark
Sponsor
Psykiatrien i Region Syddanmark
Condition
Depression
Drug study icon
CompletedEUCTR 2011-002585-20

The role of vitamin D supplementation on well-being and symptoms of depression during the Winter season in health service staff.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Denmark
Sponsor
Psykiatrien i Region Syddanmark
Condition
Depression
Drug study icon
CompletedEUCTR 2011-000396-14

The use of Ketamine as an anaesthetic during electroconvulsive therapy (ECT) for depression: does it improve treatment outcome?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
University of Aberdeen [...] 1. University of Aberdeen 2. NHS Grampian
Condition
Depression
Drug study icon
CompletedEUCTR 2018-004112-21

TOLERABILITY, SAFETY AND EFFICACY OF VORTIOXETINE FOR TREATMENT OF DEPRESSION IN PARKINSON’S DISEASE: A 16 WEEK OPEN LABEL STUDY

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Italy
Sponsor
IRCCS SAN RAFFAELE PISANA GESTITO DA SAN RAFFAELE ROMA SRL
Condition
Depression
Drug study icon
CompletedEUCTR 2010-023969-21

Vascular Augmentation of Late-life Unremitted Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
Gateshead Health NHS Foundation Trust
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2018-002942-35

A Randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo and standard psychological care for depression in Parkinson’s Disease

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
University College London Comprehensive Clinical Trials Unit
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2020-000469-18

A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
Initiator Pharma
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2004-000502-40

A thematic analysis of semi-structured interviews using a phenomenological approach into palliative care patients experiences of change in "fatigue" following treatment with methylphenidate – an ex...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
Southampton University Hospitals Trust
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2020-002787-32

Antidepressant for the prevention of DEPression following first episode Psychosis trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

Depression, SchizophreniaDrug
Countries
United Kingdom
Sponsor
University of Birmingham
Condition
Depression, Schizophrenia
Drug study icon
Recruitment unclearEUCTR 2004-002788-25

Hippocampal volume in young adults with moderate to severe depression before and after combined antidepressant therapy

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Germany
Sponsor
Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2009-011911-19

Impact of quetiapine prolong and escitalopram on the hypothalamic-pituitary-adrenocortical (HPA)-axis activity in depressed patients

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Germany
Sponsor
Ludwig-Maximilian-University of Munich, Department of Psychiatry
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2005-005266-37

Influence of Escitalopram on the incidence of depression and dementia following acute middle cerebral artery territory infarction. A randomized, placebo-controlled, double blind study.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Germany
Sponsor
Central Institute for Mental Health, Mannheim, Div. of Gerontopsychiatry
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.